Two questions get asked of every research peptide, and almost every certificate of analysis answers only one of them.
The first is how clean is it — what fraction of the material is the target molecule versus everything else the synthesis produced. That is HPLC purity, printed at the top of the page in large type.
The second is how much of it is there — what fraction of the powder in the vial is peptide at all, as opposed to counterion, water, and salt. That is net peptide content, an independent measurement requiring its own analytical method. A peptide can be 99% pure and still be a modest fraction of the material by mass. Both statements can be true at once, and neither is fraud.
This piece is about the second question: how net peptide content is measured, and why the standard shortcut fails on a large share of the compounds on this shelf.
What is in the vial that is not peptide
A lyophilized research peptide is not neat peptide. It reliably contains several other things:
- Counterion. Preparative RP-HPLC uses trifluoroacetic acid as an ion-pairing agent, so synthetic peptides come off the column as TFA salts unless a deliberate exchange step is performed. Every basic side chain — arginine, lysine, histidine, the free N-terminus — carries a counterion. This is covered in depth in TFA vs acetate.
- Residual water. Lyophilization removes bulk water by sublimation and much of the bound water by desorption, but never all of it. See lyophilization explained.
- Residual salts and scavengers from cleavage and workup.
- Peptidic impurities — deletion sequences, truncations, aspartimide-derived isomers. These are peptide by mass.
Synthetic peptides supplied as TFA salts commonly run around 70–90% peptide by weight, with the balance being counterion and moisture. The figure is not a quality grade. It is chemistry.
Why arginine- and lysine-rich sequences read low
Net peptide content correlates with sequence composition in a predictable way. Every basic residue is a counterion-binding site, so peptides loaded with arginine and lysine carry proportionally more non-peptide mass than neutral or acidic sequences of the same length — even when they are exceptionally pure.
A low net peptide content on a highly basic peptide is therefore an expected result, not a red flag. Conversely, an acidic sequence should not show a dramatic deficit, and if it does, moisture or residual salt is the likelier explanation.
This is the single most common misreading of the number: treating it as a purity proxy when it is largely a composition and salt-form artifact.
The subtlety nobody mentions: peptidic impurities count as peptide
Amino acid analysis measures amino acids. It does not care whether those amino acids are assembled in the correct order.
A deletion sequence — the target peptide missing one residue — is still peptide, still hydrolyzes to amino acids, and still counts toward net peptide content. So net peptide content tells you the peptidic fraction of the powder, and HPLC purity tells you what proportion of the peptidic material is the intended molecule. The two numbers are multiplicative, not interchangeable. A high figure on one line cannot rescue a low figure on the other, and neither one alone describes how much of your target molecule is present.
This is also why mass spectrometry remains necessary alongside both: a deletion sequence is invisible to amino acid analysis and can hide under a clean chromatogram, but it shows up immediately as a wrong mass.
Method 1: amino acid analysis, the reference method
Quantitative amino acid analysis (AAA) is the method that actually establishes net peptide content, and the approach codified in USP General Chapter ⟨1052⟩ for biotechnology-derived articles.
The procedure: hydrolyze the peptide back to free amino acids in strong acid at elevated temperature, separate the resulting amino acids chromatographically, quantify them against calibrated standards, and back-calculate how much peptide the sample must have contained. Because it counts amino acids by mass against a standard rather than comparing peak areas to each other, it produces an absolute quantity — which is precisely what HPLC purity cannot do.
It also has well-documented blind spots, all of them consequences of acid hydrolysis:
- Tryptophan is destroyed and requires a separate method or a modified hydrolysis (high-temperature short-duration in the presence of phenol is one published approach).
- Serine and threonine are partially destroyed, conventionally handled by hydrolysis time-course extrapolation.
- Asparagine and glutamine deamidate to aspartic and glutamic acid, so results are reported as Asx and Glx rather than resolved.
- Cysteine and methionine recover poorly or oxidize.
The practical consequence is that routine acid hydrolysis reliably quantifies 17 of the 20 proteinogenic amino acids, and a lab reporting net peptide content on a Trp-containing sequence should be able to say how tryptophan was handled.
Two further limits matter for this catalog specifically. Non-proteinogenic residues are not standard analytes — the Aib in lipidated incretins, the 2′,6′-dimethyltyrosine in SS-31, the naphthylalanine in ipamorelin — each requires a method validated to resolve it. And AAA is blind to chirality: hydrolysis of a D-peptide yields D-amino acids that co-elute with their L-counterparts on standard methods, so a D-retro-inverso construct like FOXO4-DRI can quantify perfectly while telling you nothing about stereochemistry. That gap was covered in synthesis routes and impurity profiles.
Method 2: UV spectrophotometry, and the trap in it
The fast alternative is to measure absorbance at 280 nm and divide by a predicted extinction coefficient. The coefficient is estimated directly from sequence using the values refined by Pace et al. (Protein Science, 1995): roughly 5,500 M⁻¹cm⁻¹ per tryptophan, 1,490 per tyrosine, and 125 per cystine (disulfide, not free thiol).
Read that list again and the problem becomes obvious. The equation has exactly three inputs, and a large share of the compounds on this shelf contain none of them.
BPC-157 (GEPPPGKPADDAGLV), Epithalon (AEDG), KPV, and Selank (TKPRPGP) have no tryptophan, no tyrosine, and no disulfide. Their predicted absorbance at 280 nm is essentially zero. A 280 nm reading on any of them is noise, and a quantitation derived from it is meaningless. Compounds like MOTS-c and semaglutide, which carry both Trp and Tyr, quantify at 280 nm without difficulty — the method is not broken, it is just conditional on composition.
There is a documented workaround: the peptide backbone amide bond absorbs in the far UV, and Anthis & Clore (Protein Science, 2013) published a way to predict molar absorptivity at 205 nm from sequence, explicitly to quantify proteins and peptides lacking Trp and Tyr. This is also why analytical HPLC purity is read at 210–220 nm rather than 280 — the backbone is the universal chromophore.
Far-UV quantitation carries its own constraint, and it loops back to the counterion: TFA absorbs strongly in the same region. Residual trifluoroacetate, buffers, and organic solvents all contribute background where the amide bond is being measured. Sample matrix stops being a detail and becomes the dominant error term.
Elemental nitrogen determination is a third route, but it cannot distinguish peptide nitrogen from nitrogenous contaminants.
Method 3: Karl Fischer, for the water
Net peptide content accounting is incomplete without knowing the moisture load. Karl Fischer titration measures water content specifically — as opposed to loss-on-drying, which measures everything volatile — and it is the standard tool for residual moisture in a lyophilized cake.
Water is doing two jobs on a COA. It is non-peptide mass to be subtracted, and it is the reactant in backbone hydrolysis and the mobility that permits deamidation and aggregation. A residual-moisture figure is simultaneously a quantitation input and a stability predictor, which is why it belongs next to the storage discussion in peptide stability and degradation pathways.
Where the concept does not apply at all
Net peptide content assumes a defined molecule of known sequence. Several catalog items break that assumption:
- HCG and HMG are heterodimeric glycoproteins whose active species is a glycoform mixture. Their potency is assigned in International Units by bioassay against an international reference standard, not by mass. A net peptide content figure would not be more rigorous — it would be less informative.
- Thymalin is a heterogeneous thymic fraction. A percentage on a mixture is not a characterization number.
- NAD+, AICAR, and 5-Amino-1MQ are not peptides. Acid hydrolysis to amino acids is not a meaningful operation on any of them, and their documentation should look like small-molecule documentation.
A test only carries information if it can detect a failure mode the material is capable of. Applying peptide accounting to a glycoprotein or a nucleoside analog produces a number that looks like rigor and isn't.
Why this matters for research reproducibility
Concentration error is the quietest failure mode in peptide research. It does not produce an obvious artifact — it produces results that are internally consistent, publishable, and shifted.
If a nominal quantity is assumed to be pure peptide when it is meaningfully less, every derived molar concentration inherits that error, and so does every potency figure computed from it. As covered in the receptor pharmacology primer, EC₅₀ values are already only comparable within a single assay system; adding an unquantified concentration offset makes cross-study comparison worse still. Two labs working from the same nominal amount of material from different lots can generate genuinely different curves without either one making a procedural mistake.
On the COA, look for the method, not just the number. "Net peptide content: 84.2% (AAA)" is a measurement. A bare percentage with no method named is an assertion. And an absent line means not determined — which is a known unknown, and the appropriate response is to ask rather than to assume.
FAQ
Is a net peptide content below 100% a sign of a bad product? No. For a TFA-salt synthetic peptide it is the expected result, and it is driven substantially by how many basic residues the sequence carries. What matters is whether the figure was measured and disclosed, and whether it is consistent with the sequence's composition.
Can net peptide content be calculated from HPLC purity? No. HPLC purity is a relative area comparison among UV-detected species; net peptide content is an absolute mass fraction determined against calibrated standards. Non-peptide mass such as counterion and water is largely invisible to the HPLC detector, so no arithmetic converts one number into the other.
Why do some COAs report net peptide content and others do not? Because it requires a separate assay — amino acid analysis or a validated spectrophotometric method — with its own cost and turnaround. Its presence signals that the analytical package went beyond the default chromatogram-and-mass pair. Its absence is not proof of a problem, but it does mean the mass accounting has not been done.
For our full documentation standards, see Quality & Testing, or browse the compound library.
This article is educational and for the laboratory research community. Trulogic Labs products are sold for laboratory and research use only and are not for human consumption.